As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: February 15, 2015
by Zee News:
Type 2 diabetes reduces quality of life and researchers have now found that it may also decrease certain cognitive abilities, known as executive functions.
Type 2 diabetes is associated with bad performance on cognitive tests, measuring abilities involved in the control of emotions, behaviour and thought, the findings showed.
“This facet of brain function is particularly important because we rely on it when we are attempting to behave in a way that is contrary to our natural inclinations or what the environment impels us to do,” said lead author Corrie Vincent from the University of Waterloo in Canada.
The researchers reviewed 60 studies, comparing 9,815 individuals with type 2 diabetes to 69,254 controls without it and examined their performance on measures of executive function.
“Essentially people with type 2 diabetes may be hit with the double whammy of having more need for executive control but – possibly because of the disease’s effect on the brain – less intact resources for exerting it,” senior author Peter Hall, professor at the University of Waterloo, added.
Approximately 600 million people live with type 2 diabetes worldwide, with nearly 800 million cases expected by 2030, making it one of the greatest global health concerns of modern times.
“Fortunately, there are a few things that can help optimise the brain structures that support executive function,” Hall said.
“Aerobic exercise and cognitively challenging activities – such as learning new things, solving difficult puzzles and other problem solving activities – all help to keep your brain sharp,” said Hall.
The study appeared in the journal Psychosomatic Medicine.
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.